Impact of cardiopulmonary bypass on platelet lipids and bleeding after cardiac surgery
Official title: Change in Platelet Lipid Metabolism and Procoagulant Phenotype Induced by Cardiopulmonary Bypass. Impact on Postoperative Inflammatory Response and Bleeding Complications During Cardiac Surgery.
Run by Université Catholique de Louvain · NCT07630987 · Data updated 2026-11-12
This study tests how CPB changes platelet lipid metabolism and procoagulant platelets to see if these changes relate to inflammation and bleeding after cardiac surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Université Catholique de Louvain Academic / other |
| Drugs / interventions | chemotherapy, immunotherapy |
| Locations | 1 site (Brussels) |
| Status | Recruiting |
| Started | April 15, 2026 |
| Main results expected | January 2029 |
| Study ends | January 2030 |
| Registry record updated | November 6, 2026 |
| Trial ID | NCT07630987 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with coronary disease and/or severe valvular disease undergoing elective cardiac surgery with CPB.
✕Probably not a fit
Patients without CPB exposure or those not experiencing CPB-related platelet alterations may see no direct benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The PLACARD project investigates how cardiopulmonary bypass alters platelet lipid metabolism and the formation of procoagulant platelets in patients undergoing cardiac surgery. Researchers will analyze platelet lipid profiles and bioenergetics before, during, and after surgery and relate these ex vivo findings to postoperative inflammatory markers and bleeding outcomes in the ICU. The study uses arterial blood sampling at multiple time points to characterize the hemostatic and inflammatory milieu associated with CPB. It aims to clarify whether CPB-induced platelet changes contribute to adverse postoperative events and whether these pathways could be targeted to improve outcomes.
Why it matters
Potential benefit: If successful, the study could illuminate mechanisms linking CPB, platelet biology, and postoperative inflammation and bleeding, potentially guiding future therapies to reduce complications.
How similar studies have gone: Prior work suggests platelet lipid metabolism can influence thrombo-inflammatory responses, but the specific CPB-related platelet lipid changes in this context are exploratory.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adult patients (≥ 18 years old) suffering from coronary disease and/or severe valvular dysfunction (mitral or aortic) undergoing elective coronary angiography or cardiac surgery with cardiopulmonary bypass. Exclusion Criteria: * Uninterrupted preoperative dual antiplatelet therapy * Active chronic inflammatory disease * Recent chemotherapy or immunotherapy (\< 3 months) * Active solid malignancy * History of hematologic malignancy * Hemophilia or other coagulopathy * History of thrombocytopenia (\< 100,000 platelets/mm³) * Recent administration of thrombopoietin receptor agonist or immunoglobulins * History of thrombopathy, thrombocytosis, or myeloproliferative syndrome * History of heparin-induced thrombocytopenia (HIT) * Cirrhosis or hepatic fibrosis (with or without hypersplenism) * History of splenectomy, regardless of initial indication * History of systemic autoimmune disease (e.g., systemic lupus erythematosus, scleroderma, antiphospholipid syndrome, systemic vasculitis) * Recent major surgery (\< 3 months) * Severe renal insufficiency (eGFR ≤ 30 mL/min/m²) with or without dialysis * Recent or chronic corticosteroid therapy * Recent acute coronary syndrome, STEMI type (\< 3 months) * Urgent surgery or procedure * Preoperative hemodynamic instability
Where it's running
-
Cliniques universitaires Saint-Luc
Brussels, Belgium Recruiting
Study contacts
- Study coordinator: Christophe Beauloye, MD, PhD
- Email: christophe.beauloye@uclouvain.be
- Phone: 003227642812
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Integrated intraoperative hemodynamic monitoring during cardiac surgery with CPB
This pilot study tests a single-dashboard monitoring system to see if it can capture heart and tissue perfusion data during elective cardiac surgery with bypass in adults without changing patient care.
-
Transcutaneous auricular vagus nerve stimulation to prevent kidney injury after heart surgery
This trial tests whether applying a non-invasive ear stimulation (taVNS) around the time of elective heart surgery can help prevent acute kidney injury in adults undergoing cardiopulmonary bypass.
-
Eurosets arterial and venous cannulas for cardiopulmonary bypass procedures
This trial will test Eurosets arterial and venous cannulas during cardiopulmonary bypass in adults having elective coronary or aortic valve surgery to see if they are as safe and work as well as Medtronic cannulas.
-
Personalized lung volume optimization with PEEP titration for children after heart surgery or with severe respiratory failure
This trial tests whether a personalized lung volume optimization maneuver using PEEP titration can improve heart and lung function in children after cardiopulmonary bypass surgery or in those with severe respiratory failure at risk for ECMO.
-
Autologous Cold-Stored Platelets for Complex Cardiac Surgery
This study tests whether using a patient’s own cold-stored platelets, donated 7–10 days before surgery, improves outcomes for adults undergoing complex cardiac procedures compared with standard allogeneic platelets.
-
Using Nitric Oxide to Improve Recovery in Heart Surgery
This study tests if inhaling nitric oxide during heart surgery can help adults recover better and avoid complications like kidney problems and breathing issues.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.